INHIBITION OF NATURAL KILLER (NK) CELL CYTOTOXICITY BY INTERLEUKIN-6: IMPLICATIONS FOR THE PATHOGENESIS OF MACROPHAGE ACTIVATION SYNDROME (MAS)